These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 16477462

  • 21. Nose drops induce vasomotion in the microcirculation of the sinus mucosa of the rabbit.
    Bende M, Arfors KE, Intaglietta M.
    ORL J Otorhinolaryngol Relat Spec; 1993; 55(2):110-3. PubMed ID: 7680443
    [Abstract] [Full Text] [Related]

  • 22. [Tolerance and effectiveness of oxymetazoline and xylometazoline in treatment of acute rhinitis].
    Dorn M, Hofmann W, Knick E.
    HNO; 2003 Oct; 51(10):794-9. PubMed ID: 14523532
    [Abstract] [Full Text] [Related]

  • 23. [The rebound of nasal resistance after decongestant used in nose].
    Shen J, Huang X, Xiang J, Shu H.
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1999 Dec; 13(12):560-1. PubMed ID: 12541428
    [Abstract] [Full Text] [Related]

  • 24. [Immunoelectron microscopic findings in patients with allergic rhinitis].
    Knipping S, Holzhausen HJ, Riederer A, Agha-Mir-Salim P, Berghaus A.
    Laryngorhinootologie; 2002 Dec; 81(12):861-5. PubMed ID: 12486623
    [Abstract] [Full Text] [Related]

  • 25. Effect on the nasal mucosa of long-term treatment with oxymetazoline, benzalkonium chloride, and placebo nasal sprays.
    Graf P, Hallén H.
    Laryngoscope; 1996 May; 106(5 Pt 1):605-9. PubMed ID: 8628089
    [Abstract] [Full Text] [Related]

  • 26. Rhinitis medicamentosa: what an otolaryngologist needs to know.
    Doshi J.
    Eur Arch Otorhinolaryngol; 2009 May; 266(5):623-5. PubMed ID: 19096862
    [Abstract] [Full Text] [Related]

  • 27. Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis.
    Watanabe H, Foo TH, Djazaeri B, Duncombe P, Mackay IS, Durham SR.
    Rhinology; 2003 Sep; 41(3):167-74. PubMed ID: 14579657
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Treatment of rhinitis medicamentosa with fluticasone propionate--an experimental study.
    Elwany S, Abdel-Salaam S.
    Eur Arch Otorhinolaryngol; 2001 Mar; 258(3):116-9. PubMed ID: 11374251
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. An evaluation of nasal response following different treatment regimes of oxymetazoline with reference to rebound congestion.
    Morris S, Eccles R, Martez SJ, Riker DK, Witek TJ.
    Am J Rhinol; 1997 Mar; 11(2):109-15. PubMed ID: 9129752
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Studies of rhinitis medicamentosa.
    Wang JQ, Bu GX.
    Chin Med J (Engl); 1991 Jan; 104(1):60-3. PubMed ID: 1879198
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.